Pfizer’s pill is the second oral drug for COVID-19 to be proven strongly effective in large, placebo-controlled clinical trials after Merck’s molnupiravir, which early in …
Roche’s anti-inflammatory drug Actemra did not help patients hospitalized with severe COVID-19-associated pneumonia, according to Phase 3 results announced by the Swiss drugmaker Wednesday. Treatment …
